Univercells part of Gates-backed group trying to cut polio vaccine cost
The Bill & Melinda Gates Foundation has granted Univercells $12m (€12.5m) to develop a vaccine manufacturing platform that lowers production costs.
Archives for December 16, 2016
GSK opens first US vaccine R&D site in Maryland next to non-profit public health unit
The new $50m facility will house 450 scientists in Rockville, Maryland to work across 12 vaccine development programmes, alongside the non-profit Biopreparedness organisation (BPO).